Abiopharma

🔍 Marmurek Eric S (Executive)

Company: Ribbon Communications Inc. (RBBN)

Report Date: 2026-04-15

Detailed Transactions and Holdings:

• Acquired 37,500 shares of Common Stock (Direct)
  Date: 2026-04-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 464,563.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 14,756 shares of Common Stock at $2.48 per share (Direct)
  Date: 2026-04-15 | Code: F | equity_swap_involved: 0 | shares_owned_after: 449,807.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 37,500 shares of Restricted Stock Units (RSUs) (Derivative)
  Date: 2026-04-15 | Code: M | equity_swap_involved: 0 | shares_owned_after: 37,500.00 | transaction_form_type: 4 | Footnotes: F1, F3, F3

Footnotes:

• F1: Eash RSU represents a contingent right to receive one share of the Registrant's common stock.
• F2: Reflects shares of common stock withheld by the Registrant to satisfy tax withholding obligations in connection with the vesting.
• F3: The RSUs were issued on October 15, 2024. The remaining RSUs vest on October 15, 2026.